Based on our prior findings that A-FABP levels are elevated in obese and postmenopausal women, and elevated A-FABP promotes obesity-associated BC development[8], we wondered if one or more oestrogens would be associated with A-FABP. The gene discussed is FABP4; the disease is obesity due to melanocortin 4 receptor deficiency.